Impact of Albendazole -Ivermectin on Wuchereria Bancrofti in Mali
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
Lymphatic filariasis is a public health problem in Mali. The existing data are not up to date
and most of them are more than 15 years old. To address this issue in April 2000, the
investigators started studies to update the epidemiology of lymphatic filariasis. There is no
ongoing lymphatic filariasis control program in 2000 in Mali in terms of preventive
chemotherapy treatment or vector control.
To fill these gaps, this current study aims to assess the impact of albendazole-ivermectin
combination treatment on Wuchereria bancrofti infection and transmission in 6 rural highly
endemic villages of Mali.
Phase:
Phase 4
Details
Lead Sponsor:
Centre d'Appui à la lutte contre la Maladie
Collaborators:
Malaria Research and Training Center, Bamako, Mali World Health Organization